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Higher Usual Dietary Intake of Phytoestrogens Is Associated
With Lower Aortic Stiffness in Postmenopausal Women
Yvonne T. van der Schouw, Anouk Pijpe, Corinne E.I. Lebrun, Michiel L. Bots, Petra H.M. Peeters,
Wija A. van Staveren, Steven W.J. Lamberts, Diederick E. Grobbee
Objective—Phytoestrogens have been postulated to protect against cardiovascular diseases, but few studies have focused
on the effect of Western dietary phytoestrogen intake.
Methods and Results—Four hundred three women with natural menopause either between 1987 and 1989 or between 1969
and 1979 were selected from the baseline data of the PROSPECT study (n17 395). Isoflavone and lignan intake was
calculated from a food-frequency questionnaire. Aortic stiffness was noninvasively assessed by pulse-wave velocity
measurement of the aorta. Linear regression analysis was used. After adjustment for age, body mass index, smoking,
physical activity, mean arterial pressure, follow-up time, energy intake, dietary fiber intake, glucose, and high density
lipoprotein cholesterol, increasing dietary isoflavone intake was associated with decreased aortic stiffness: 0.51 m/s
(95% CI 1.00 to 0.03, fourth versus first quartile, P for trend0.07). Increasing dietary intake of lignans was also
associated with decreased aortic pulse-wave velocity: 0.42 m/s (95% CI 0.93 to 0.11, fourth versus first quartile, P
for trend0.06). Results were most pronounced in older women: for isoflavones, 0.94 m/s (95% CI 1.65 to 0.22,
P for trend0.02), and for lignans, 0.80 m/s (95% CI 1.85 to 0.05), fourth versus first quartile.
Conclusions—The results of our study support the view that phytoestrogens have a protective effect on the risk of
atherosclerosis and arterial degeneration through an effect on arterial walls, especially among older women.
(Arterioscler Thromb Vasc Biol. 2002;22:1316-1322.)
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Phytoestrogens are naturally occurring plant compoundswith a chemical structure comparable to that of estradiol.1
Phytoestrogens can be divided into 3 major categories:
isoflavones, lignans (precursors and naturally occurring), and
coumestans.2 Because phytoestrogens are capable of binding
to the estrogen receptor, they may have the potential to mimic
estrogenic effects.3,4
See p 1245
Phytoestrogens have been suggested to lower the risk of
coronary heart disease (CHD). In nonhuman primates, isofla-
vones in soy protein have been found to improve cardiovas-
cular disease risk factors,5 in particular, serum lipids, and to
inhibit the progression of coronary artery atherosclerotic
lesions.6–8 A meta-analysis of the effects of soy protein
supplement action on serum lipids in humans found decreases
in serum concentrations of 9.3% for total cholesterol, 12.9%
for LDL cholesterol, and 10.5% for triglycerides.9 Phy-
toestrogens have been reported to have antioxidative effects
on LDL cholesterol.10,11 Another possibility of phytoestrogen
action is their possible effect on arterial walls through an
effect on vascular reactivity. Animal studies found an im-
provement of vascular reactivity after supplementation of
soy-containing isoflavones compared with isoflavone-devoid
soy.12,13 In Australian postmenopausal and perimenopausal
women, systemic arterial compliance (or arterial stiffness)
has been found to improve by22% after supplementation of
high amounts of tablets containing soy isoflavones14 or
isoflavones from red clover.15
Most investigators of the possible effects of phytoestrogens
on tissues studied phytoestrogen supplements that contain
amounts of phytoestrogens that are normally only reached in
Asian populations (20 to 80 mg/d.)16 Very little is known
about the effects on tissues of the amount of phytoestrogens
that Western populations consume in their usual diet (1
mg/d).17 In a very recent study among postmenopausal
women, women with a usual dietary intake of genistein (one
of the isoflavones) of 1.0 mg/d had a significantly lower
body mass index (BMI), waist circumference, and fasting
insulin level than did those with no daily genistein consump-
tion.18 Furthermore, in adjusted analyses, genistein, daidzein
(both isoflavones), and total isoflavone intake were each
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positively associated with HDL cholesterol and negatively
related to post–glucose-challenge insulin. Earlier work from
our group has shown a high usual dietary intake of phy-
toestrogens to be associated with a favorable metabolic
cardiovascular risk profile.19 All of these previous findings
suggest the protective role of dietary soy intake against
cardiovascular disease (risk factors) in postmenopausal
women.
Because atherosclerosis and arterial stiffness are likely to
predate the development of symptomatic CHD, pulse-wave
velocity (PWV) measurements might be useful to detect
cardiovascular risk at an early stage, before clinical manifes-
tations have occurred. Phytoestrogens may have a positive
effect on the postmenopausal risk of atherosclerosis and
arterial degeneration, possibly through an effect on vascular
walls. Therefore, we are interested in the relationship be-
tween the usual dietary intake of phytoestrogens and stiffness
of the aorta, measured by PWV, in postmenopausal women.
Methods
Subjects
For the present study, participants were recruited from the PROS-
PECT study, 1 of the 2 Dutch cohorts participating in the European
Prospective Investigation Into Cancer and Nutrition (EPIC).20 In
PROSPECT, a total of 17 365 healthy breast-cancer–screening
participants, aged 49 to 70 years, living in Utrecht and surroundings
were enrolled between 1993 and 1997. The purpose of the
PROSPECT-EPIC study is to assess the relationship between nutri-
tion and cancer and other chronic diseases. For the present study, 2
groups of women who had experienced a natural menopause either
between 1987 and 1989 or between 1969 and 1979 were selected
from the baseline data of PROSPECT. In addition, women were
required to have an intact uterus and at least 1 intact ovary and
should not have used sex steroids after the reported date of last
menstruation. These criteria were used because the primary objective
of the present study was to elucidate the role of endogenous
estrogens on markers of frailty and to determine whether this role
was different for women with a longer menopausal time span (20 to
30 years) compared with women with a shorter menopausal time
span (8 to 12 years). Of 1802 eligible women (1149 with shorter
menopausal and 653 with longer menopausal time spans), 902
women (451 with shorter menopausal and 451 with longer meno-
pausal time spans) were invited by a personal letter from the
principal investigator of PROSPECT, and 553 (61%) answered
positively. The aim of the present study was to enroll 200 women in
each group (2 groups with different intervals of time since meno-
pause: women with a shorter menopausal time span and women with
a longer menopausal time span). Eventually, 403 participants (207
with shorter menopausal and 196 with longer menopausal time
spans) were included in the study. Women were considered suffi-
ciently healthy to participate when they were physically and mentally
able to visit the study center independently. Each participant under-
went all tests and assessments during 2 visits to the study center. The
present study was approved by the Institutional Review Board of the
University Medical Center Utrecht, and written informed consent
was obtained from all participants. Data collection took place
between September 1999 and March 2000.
FFQ and Scoring Phytoestrogen Intake
At the baseline visit of the PROSPECT study, a validated food-
frequency questionnaire (FFQ) was administered, designed to esti-
mate regular intake of 178 food items in the year before enroll-
ment.21,22 As previously described in detail,17 by using information
in the literature, we calculated and assigned for each food item in the
FFQ the values for the isoflavones (daidzein, genistein, formonon-
etin, biochanin A, and coumestrol) and for the lignans (matairesinol
and secoisolariciresinol). Each phytoestrogen content of a food item
was then scored in 7 categories (Table 1), according to the following
procedure. All values found in the literature were converted to
milligrams per 100 g food. Values expressed on a dry weight basis
were concerted to wet weight basis either by using the moisture
content for that particular food or by using adjustments for the
method of preparation. When the specific phytoestrogen content was
reported as “a trace” or “traceable,” the value of 0.00001 mg/100 g
was appointed. This value is based on sensitivity of the method used.
When more values were reported from the same or different original
sources in the literature, we used the highest value to score the
phytoestrogen content of a food. If wet and dry weights were
reported from different original sources in the literature, we used the
reported wet weight value to score. If the questionnaire listed similar
food items on the same line, we used the phytoestrogen data for the
food most commonly eaten. If values for the most common food
were unavailable, any value found on 1 of the other food items in line
was used. If there was no information about the phytoestrogen
content of a food item, a value was assigned by using data of a
similar food item if available; if not, the value zero was imputed. By
use of the Nutrition Data system of the University of Minnesota, the
amount of phytoestrogen in breakfast cereals was estimated, with the
fiber content of the cereal used as a proxy for the phytoestrogen
content. The average phytoestrogen content of wheat, triticale, and
rye was used to estimate the amount of phytoestrogen per gram fiber.
Finally, we multiplied the score of each food item by the serving size
of the food. This final amount of each food item was multiplied by
the frequency of the consumption of that food item and then summed
across foods to obtain the total individual dietary intake of each
group of phytoestrogens.
Measurements
Information on health was obtained by taking the medical history, by
registration of current medication, and by physical examination. A
standardized history of estrogen use, alcohol consumption, and
smoking was obtained from all women as part of the medical history.
Anthropometric measures included height, weight, and waist and hip
circumferences. From these measures, BMI (kg/m2) and body fat
distribution were calculated. The Voorrips questionnaire23 was
administered to assess physical activity. This questionnaire has been
validated in an elderly population.23 Blood pressure and heart rate
were measured during the first visit by an oscillometric automated
device (DINAMAP 8100, Critikon). Measurements were conducted
before 11:00 AM after an overnight fast. After 5 minutes of rest,
blood pressure was taken at the right brachial artery simultaneously
with heart rate measurement, twice with the participant in supine
position, with 1 minute between each measurement. Systolic and
diastolic blood pressures were taken as the average of the 2
measurements. Mean arterial pressure was calculated as diastolic
blood pressure1/3(systolic blood pressurediastolic blood pres-
sure). Pulse pressure was defined as systolic blood pressure minus
diastolic blood pressure. Fasting venous blood samples were ob-
tained between 8:00 and 11:00 AM. Total cholesterol, HDL choles-
terol, triglyceride, glucose, and albumin levels were reflectometri-
cally measured by using commercial enzymatic kits with a Vitros
TABLE 1. Scoring of Phytoestrogen Content of Food Item
Phytoestrogen Content
(mg/100 g Wet Weight)*
Scoring Value
(mg/100 g)
Non detectable, 0 0
0*0.001 0.0005
0.001*0.01 0.005
0.01*0.1 0.05
0.1*1 0.5
1*10 5
10 50
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250 (dry chemistry, Johnson & Johnson). Glucose was measured by
the glucose oxidase/peroxidase method. Total cholesterol was mea-
sured by adaptation of the cholesterol oxidase/peroxidase method
(fixed time). Triglycerides were measured by the lipase/glycerol
kinase/glycerol phosphate oxidase/peroxidase method (fixed time).
HDL cholesterol was measured after precipitation with dextran
sulfate/Mg2. The LDL cholesterol concentration was estimated by
using the Friedewald formula.24
Aortic Stiffness
The Sphygmocor system (PWV system, PWV Medical) was used to
noninvasively measure stiffness of the aorta.25 After the subject had
rested for 5 to 10 minutes in supine position, aortic PWV was
measured by sequentially recordings of arterial pressure waveform at
the carotid artery and the femoral artery by using a hand-held
micromanometer-tipped probe on the skin at the site of maximum
arterial pulsation. Gating the recordings at those 2 sites to the ECG
allowed the PWV to be measured. Recordings were taken when a
reproducible signal was obtained with high-amplitude excursion, ie,
usually 10 consecutive beats to cover the complete respiratory cycle.
The wave transit time was calculated by the system software, with
the R wave of a simultaneously recorded ECG used as a reference
frame. Distances from the carotid-sampling site to the suprasternal
notch and suprasternal notch to the femoral artery were measured
with a compass.26 The aortic PWV (m/s) was automatically calcu-
lated as the distance between the suprasternal notch and the femoral
artery minus the distance between the carotid sampling site and the
suprasternal notch, divided by the time interval between systolic R
wave and femoral systolic upstroke minus the time interval between
systolic R wave and carotid systolic upstroke. Aortic PWV was
determined as the mean of at least 3 consecutive beats recorded
during 10 seconds of data acquisition. A higher PWV indicates
increased aortic stiffness. All measurements were performed by the
same observer. A reproducibility study was performed among 27
participants, who underwent a second PWV measurement within 2
weeks after the first examination. The intraclass correlation coeffi-
cient was 89.6%, indicating that 89.6% of the variance in the PWV
measurements was due to patient differences, whereas 10.4% could
be attributed to differences between visits.
Data Analysis
Dietary intake of total phytoestrogens, isoflavones, and lignans was
categorized into quartiles. The relationship of dietary intake of
isoflavones and lignans with aortic PWV was determined by linear
regression analysis. Aortic PWV was included in the model as a
continuous variable (m/s). Data on aortic PWV were not available
for 18 women. Data on dietary intake of isoflavones and lignans
were not available for 3 women. Residual analysis was performed to
identify possible outliers (defined as 3 SD remote from the mean).
Three outliers were detected, of which it was very likely that errors
in measurement of PWV were the cause. All together, 379 women
remained for analysis.
Because dietary intake of phytoestrogens was calculated from the
baseline FFQ of PROSPECT and because aortic PWV was assessed
in the present study several years later, all analyses are adjusted for
follow-up time. Other confounders that were considered in the
analysis included age (y), BMI (kg/m2), smoking (never, past,
current), physical activity (Voorrips score), mean arterial pressure
(mm Hg), time since menopause (short, long), energy intake (kJ/d),
fiber intake (g/d), fruit intake (g/d), vegetable intake (g/d), alcohol
intake (g/d), glucose level (mmol/L), and HDL cholesterol level
(mmol/L).
Results were considered statistically significant at a 2-sided
P0.05. Statistical analyses were performed by using the program
SPSS, version 9.0.
Results
General Characteristics
General characteristics of the total study population by
quartiles of total phytoestrogen intake are presented in Table
2. The mean age of the total study group was 66.2 years (SD
3.8). The mean aortic PWV of all participants was 9.14 (SD
2.00). The dietary intakes of isoflavones and lignans of the
total study population and of each postmenopausal time-span
group separately are presented in Table 3. The median dietary
intakes of isoflavones and lignans were 0.14 (interquartile
range 0.09 to 0.24) and 0.63 mg/d (interquartile range 0.33 to
0.89 mg/d), respectively.
Linear Regression Analysis
In Table 4, adjusted regression coefficients, CIs, and proba-
bility values by quartile categories of isoflavones and lignans
for all participants are given. The final regression models
included follow-up time (mo), age (y), smoking (never, past,
current), BMI (kg/m2), physical activity (Voorrips score),
mean arterial pressure (mm Hg), energy intake (kJ/d), dietary
fiber intake (g/d), glucose level (mmol/L), and HDL choles-
terol level (mmol/L). Other potential confounders did not
materially change the regression coefficients. A high dietary
intake of isoflavones was statistically significantly associated
with decreased aortic stiffness (fourth quartile 0.52 [95%
CI 1.00 to 0.04] compared with the first quartile). An
increased dietary intake of lignans was also associated with
decreased aortic stiffness (PWV in second quartile, 0.47
m/s [95% CI 0.92 to 0.02], PWV in third quartile, 0.78
m/s [95% CI 1.25 to 0.31], and PWV in fourth quartile,
0.42 m/s [95% CI 0.93 to 0.10] compared with the first
quartile).
Subgroup Analysis
For women with a longer postmenopausal time span, a higher
dietary intake of almost all phytoestrogen subgroups was
associated with a less stiff aorta (Table 5). A dietary intake of
isoflavones of 0.24 mg/d significantly decreased aortic
PWV by 0.94 m/s (95% CI 1.65 to 0.23). Likewise, an
increased dietary intake of lignans was associated with a less
stiff aorta: with 0.71 m/s (95% CI 1.32 to 0.09), 0.75
m/s (95% CI 1.42 to 0.08), and 0.81 m/s (95% CI
1.54 to 0.07) for the second, third, and fourth quartiles,
respectively, compared with the first quartile (Figures 1 and 2).
Discussion
Overall, we found that a higher regular intake of phytoestro-
gens within Western countries is associated with lower aortic
stiffness among postmenopausal women, regardless of the
low range of intake in this population.
Before we interpret our results, some issues concerning the
measurement of aortic stiffness and the FFQ need to be
addressed. In the present study, arterial stiffness was deter-
mined by measuring PWV. Observational studies have con-
sistently shown that unfavorable levels of established cardio-
vascular risk factors are related to increased aortic
stiffness.27,28 Increased arterial stiffness has been related to
atherosclerosis,29,30 and recently, it has been shown to
strongly predict cardiovascular events.31–36
Another issue that needs to be addressed concerns the
usage of the FFQ in the present study. With the FFQ that we
have used, we were able to quantify the usual dietary intake
of phytoestrogens in the previous year. This is especially
1318 Arterioscler Thromb Vasc Biol. August 2002
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important for a study on dietary intake of phytoestrogens,
because food items containing high amounts of phytoestro-
gens are more likely to be consumed weekly or monthly and
not on a daily basis. Dietary assessment methods, such as
24-hour dietary recall and food record methods, represent a
relatively short period of intake. The underlying principle of
the FFQ is that a long-term dietary pattern can be the
conceptually important exposure rather than intake of a few
days.37 By using information in the literature, values for
isoflavones and lignans were assigned for each food item in
the FFQ. We decided to score the highest value reported in
the literature into 7 categories (Table 1) and to use the scores
instead of the exact measurements of phytoestrogen content
reported in the literature. By using this method, we avoided
the suggestion of a degree of precision for which the reported
data in the literature are too limited and too preliminary. In
addition, this system will decrease the degree of misclassifi-
cation of our determinant of interest, dietary intake of
phytoestrogens, considerably.
A further concern is residual confounding due to unmea-
sured or unknown factors. Increased phytoestrogen intake
could be a marker of healthy lifestyle. To address this, we
adjusted all analysis for BMI, smoking, and physical activity
as most important lifestyle indicators. However, we cannot
entirely exclude residual confounding by other unmeasured
lifestyle indicators.
Furthermore, confounding due to other nutrient intakes is
potentially important. However, the availability of extensive
FFQ data on other nutrients enabled adjustment in the
multivariate analyses. We adjusted for dietary fiber intake
because dietary phytoestrogens are present in foods that
contain fiber as well and because dietary fiber intake is
TABLE 2. General Characteristics of the Study Population, by Quartiles of Total
Phytoestrogen Intake (MeanSD)
Characteristic Quartile 1 N94 Quartile 2 N95 Quartile 3 N95 Quartile 4 N95
Age, y 67.33.7 66.03.8 65.63.9 65.93.6
Age at menopause, y 48.84.4 50.03.9 50.14.8 50.04.8
BMI, kg/m2 25.94.1 27.14.1 25.53.8 25.34.3
Waist-Hip ratio 0.87.0102 0.87.4102 0.86.6102 0.86.5102
Smoking, pack-years 18.520.5 12.516.9 11.817.0 14.118.2
Physical activity, Voorrips score 11.46.6 13.97.7 14.76.5 14.27.1
Follow-up time, months 47.69.5 46.09.0 45.68.4 45.68.8
Glucose, mmol/L 5.291.24 5.261.06 5.288.36 5.151.19
Triglycerides, mmol/L 1.490.45 1.450.79 1.430.67 1.430.73
Cholesterol, mmol/L 6.401.06 6.290.96 6.221.08 6.341.06
HDL cholesterol, mmol/L 1.500.36 1.570.44 1.530.44 1.540.38
LDL cholesterol, mmol/L 4.221.02 4.061.01 4.050.95 4.141.04
LDL-HDL ratio 2.970.96 2.831.18 2.861.14 2.931.28
Oestradiol, pmol/L 22.7516.41 19.2311.65 19.9412.43 19.0812.37
Oestron, pmol/L 52.0551.26 45.7126.81 43.2531.89 46.0529.46
Pulse wave velocity, m/s 9.772.15 9.161.99 8.971.89 8.681.81
Systolic BP, mm Hg 151.122.7 145.219.4 147.421.5 147.119.2
Diastolic BP, mm Hg 76.515.0 74.512.9 77.014.5 75.611.7
Heart rate, bpm 69.911.7 68.88.5 69.48.5 68.410.5
Mean arterial pressure, mm Hg 101.416.4 98.114.1 100.515.7 99.413.0
Energy intake, kJ/d 67141551 71021716 74511303 80931686
Protein intake, g/d 61.814.4 67.716.1 71.412.9 76.220.1
Fat intake, g/d 66.619.6 67.121.8 69.119.2 71.721.2
Carbohydrate intake, g/d 176.249.0 189.251.9 201.843.1 230.647.0
Dietary fiber intake, g/d 18.35.2 21.94.7 24.13.4 28.16.0
Alcohol intake, g/d 7.111.4 8.712.4 8.711.7 7.610.5
BP indicates blood pressure.
TABLE 3. Dietary Isoflavone and Lignan Intake of the Study Population
Phytoestrogen
Intake, mg/d
Median
(Interquartile Range)
MeanSD Total
Study Group
MeanSD Group Short
Postmenopausal Time Span
MeanSD Group Long
Postmenopausal Time Span
Isoflavones 0.14 (0.09–0.24) 0.571.97 0.652.35 0.491.46
Lignans 0.63 (0.33–0.87) 0.620.32 0.670.31 0.560.31*
*P0.05, significant difference in mean dietary intake between postmenopausal time span groups.
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inversely associated with CHD.38,39 A high dietary lignan
intake was associated with a low aortic stiffness. A possible
explanation could be that high lignan consumers eat more
plant foods of lower energy, causing a lower BMI; therefore,
they have a less stiff aorta. However, our results were
adjusted for BMI and total energy intake. Additional adjust-
ment for alcohol, fruit, and vegetable intake did not materi-
ally influence the results. However, even after proper adjust-
ment for confounders, a causal interpretation of our findings
is inherently restricted by the cross-sectional nature of the
design.
Because phytoestrogens also exert an effect on lipid
profiles,9 it could be hypothesized that the effect on arterial
walls that we found in the present study is reached through an
effect on lipids.40 However, in the present study, the lipid
levels were not correlated with dietary intake of phytoestro-
gens, so a direct effect on arterial walls may be assumed.
We found that the associations between dietary intake of
phytoestrogens and aortic stiffness were more pronounced in
older women with longer postmenopausal time spans (20 to
30 years). Several explanations are posed. A first possible
explanation for this finding is that women with shorter
postmenopausal time spans still have higher plasma estradiol
levels than women with longer postmenopausal time spans.
Therefore, the effect of phytoestrogens is possibly overshad-
owed in the first group, and the latter group could have more
estrogen receptors available. However, from further analysis
in the present study, we found that estradiol and estrone levels
do not differ significantly between the 2 postmenopausal
time-span groups and are not related to age, time since
menopause, or aortic stiffness. Additionally, no effect modi-
fication by endogenous estradiol was found (interaction
between estradiol level and dietary intake of phytoestrogens
was not significant; P0.68). Endogenously produced estra-
diol through aromatization of estrone produced in peripheral
fat tissue likewise did not modify our results, inasmuch as the
interaction between BMI (kg/m2) and dietary intake of phy-
toestrogens was not significant (P0.07).
TABLE 4. Results of the Linear Regression Analysis* for the
Total Study Group
Phytoestrogen Intake,
mg/d
Regression
Coefficient
95% Confidence
Interval P Trend
Isoflavones
0.09 Reference
0.14 0.33 0.80, 0.14
0.24 0.22 0.71, 0.27
0.24 0.51 1.00, 0.03 0.07
Lignans
0.33 Reference
0.63 0.48 0.94, 0.03
0.87 0.76 1.24, 0.29
0.87 0.41 0.93, 0.11 0.06
*Adjusted for follow-up time (mo), age (y), smoking (never, past, current),
BMI (kg/m2), physical activity (Voorrips score), mean arterial pressure (mm Hg),
energy intake (kJ/day), dietary fiber intake (g/d), glucose level (mmol/L), and
HDL cholesterol (mmol/L).
TABLE 5. Results of the Linear Regression Analysis* by Menopause Group
Phytoestrogen
Intake, mg/d
Women With Short Postmenopausal Time
Span (8–12 y), N199
Women With Long Postmenopausal Time Span
(20–30 y), N180
N
Regression
Coefficient
95% Confidence
Interval
P
Trend N
Regression
Coefficient
95% Confidence
Interval
P
Trend
Isoflavones
0.09 47 Reference 47 Reference
0.14 45 0.25 0.97, 0.46 50 0.28 0.93, 0.38
0.24 53 0.05 0.73, 0.64 42 0.34 1.07, 0.40
0.24 54 0.23 0.92, 0.46 1.00 41 0.94 1.65, 0.22 0.02
Lignans
0.33 36 Reference 58 Reference
0.63 48 0.22 0.92, 0.48 47 0.69 1.31, 0.07
0.87 56 0.73 1.43, 0.02 39 0.74 1.42, 0.06
0.87 59 0.19 0.95, 0.57 0.40 36 0.80 1.54, 0.05 0.03
*Adjusted for follow-up time (mo), age (y), smoking (never, past, current), BMI (kg/m2), physical activity (Voorrips
score), mean arterial pressure (mm Hg), energy intake (kJ/day), dietary fiber intake (g/d), glucose level (mmol/L), and
HDL cholesterol (mmol/L).
Figure 1. PWV difference (SE) in m/s with first quartile for
isoflavones and lignans in women with shorter menopausal time
spans.
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Another possible explanation for the differences found in
the effects of phytoestrogens between both postmenopausal
time-span groups might be that the initial level of aortic PWV
might have a powerful effect on changes in aortic PWV. A
higher initial PWV may be lowered more strongly than a
lower initial PWV. Because women with a longer postmeno-
pausal time span are significantly older and have a signifi-
cantly higher initial PWV, an effect of phytoestrogens on
PWV is perhaps shown sooner than in women with a shorter
postmenopausal time span, who are younger and have lower
(and therefore better) initial aortic stiffness. In addition,
information from Table 5 shows that, overall, a higher
number of women with a longer postmenopausal time span
have a lower intake and that a higher number of women with
a shorter postmenopausal time span have a higher intake of
dietary intake of phytoestrogens. All this may indicate that
even when the dietary intake of phytoestrogens is low, an
initial higher aortic stiffness can be decreased more strongly.
In conclusion, the present study found that phytoestrogens
may have a protective effect on the risk of atherosclerosis and
arterial degeneration through an effect on arterial walls,
especially among older women.
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